A. M. Pappas & Associates
Overview
AMP, a California-based start-up building audio processing technologies to empower people to hear better in their everyday lives.
Investment Focus
- Focus on life sciences companies
- Preference for early to mid-stage investments
- Interest in biotechnology and pharmaceutical sectors
- Willingness to invest in a wide range of human diseases
- Openness to companies with global market potential
Portfolio Companies
Reach A. M. Pappas & Associates directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about A. M. Pappas & Associates
What sectors does A. M. Pappas & Associates invest in?
A. M. Pappas & Associates invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Durham North Carolina. A. M. Pappas & Associates is listed as a vc in the ConnectSafely investor database.
What stage does A. M. Pappas & Associates invest at?
A. M. Pappas & Associates backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 100K - 6M.
Which regions does A. M. Pappas & Associates invest in?
A. M. Pappas & Associates invests across United States, Canada and Asia.
What companies has A. M. Pappas & Associates invested in?
A. M. Pappas & Associates's portfolio includes Plexxikon, Ultragenyx Pharmaceutical, Lumena Pharmaceuticals, LEAD Therapeutics and Balance Therapeutics.
How do I contact A. M. Pappas & Associates?
A. M. Pappas & Associates's contact details — including work email and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
